查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1854571

體外二氧化碳清除裝置市場按產品類型、接觸方式、操作模式、應用和最終用戶分類－2025-2032年全球預測

Extracorporeal CO2 Removal Devices Market by Product Types, Access, Mode of Operation, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，體外二氧化碳清除設備市場規模將達到 2.8705 億美元，複合年成長率為 8.67%。

主要市場統計數據
基準年 2024 1.4755億美元
預計年份：2025年 1.5968億美元
預測年份：2032年 2.8705億美元
複合年成長率 (%) 8.67%

本文簡要說明了影響體外二氧化碳清除技術在現代呼吸照護中日益重要作用的臨床需求、設備架構和相關人員動態。

體外二氧化碳清除技術正從專門的搶救技術發展成為重症加護、肺科和外科等領域的通用輔助性治療。臨床醫生和醫院系統越來越將體外二氧化碳清除視為複雜呼吸衰竭的標靶干預措施，尤其是在傳統通氣策略效果不佳或風險過高的情況下。隨著臨床途徑的不斷發展和設備技術的進步，體外二氧化碳清除如何融入更廣泛的呼吸治療方案，以減少人工呼吸器相關性肺損傷、促進保護性通氣並作為移植等先進療法的橋樑，正逐漸清晰地展現在人們的視野中。

本應用報告闡述了目前應用動態的臨床原理、核心設備架構和相關人員格局。報告還重點關注設備性能特徵、手術入路策略以及與醫療環境的互動，這些因素共同決定了臨床療效和可操作性。奠定這一基礎有助於讀者更好地理解後續討論，這些討論將著重探討技術曲折點、政策變革、細分市場機會以及區域性考量，這些因素將影響臨床醫生、醫院管理者和設備創新者的近期決策。

技術小型化、自動化和不斷發展的臨床模式如何重新定義體外二氧化碳清除設備的應用情境、臨床管道和採購重點

多項變革性變革正在再形成體外二氧化碳清除技術在臨床應用中的構思、設計和部署方式。技術小型化和膜性能的提升使得微創迴路、更低的血流量需求和更短的設定時間成為可能，從而使更多患者群體能夠接受治療，而不僅限於加護病房。同時，自動化和嵌入式控制演算法能夠穩定氣體交換參數，透過減少對操作者的依賴性來提高安全性，減輕訓練負擔，並擴大能夠安全啟動治療的臨床醫生範圍。

同時，臨床實踐正轉向早期療育模式，優先考慮肺部保護並避免高強度機械通氣。這種臨床重點推動了肺科醫生、加護治療監護醫生、灌注師和外科團隊之間的跨職能合作，並正在製定整合式診療路徑。供應鏈的韌性和生產的靈活性正成為醫療器材製造商的策略差異化因素，促使他們投資於模組化設計和在地化生產線。最後，來自註冊研究和現場試驗的成熟證據，使患者選擇、治療時機以及與傳統療法相比的療效對比更加清晰，從而支持了通訊協定標準化和醫保報銷的必要性。

新貿易措施對製造業、採購和臨床連續性的累積影響，正在推動整個價值鏈加速推動在地化、供應商多元化和風險緩解策略。

2025年關稅的實施和貿易政策的調整，為依賴全球供應鏈的體外二氧化碳清除技術製造商、醫療系統和採購機構帶來了複雜的考量。關稅導致零件成本上漲，促使各方更嚴格地審查供應商組合，並重新評估籌資策略。許多醫療設備製造商採取的因應措施包括：最佳化材料清單、加快國內零件供應商的資格認證，以及重新評估生產佈局，以降低進口成本波動帶來的風險。

醫院和綜合醫療系統透過重新談判供應商合約來應對這項挑戰，以提高採購彈性，並納入應對關稅和前置作業時間波動的條款。由於一些供應商優先選擇產能有限的合約夥伴，臨床團隊也受到了間接影響，這促使臨床工程和供應鏈團隊加強合作，以確保醫療服務的連續性。同時，對本地組裝和模具的投資增加，重點關注國產零件的品管和法規合規性。這一轉變也導致監管機構對醫療器材的等效性和可追溯性進行更嚴格的審查，並要求更全面地記錄零件來源和上市後監測措施。總體而言，關稅主導的市場環境加速了本地化趨勢，優先考慮供應商多元化，並凸顯了垂直整合對尋求穩定成本基礎並為臨床客戶提供可預測供應的企業的戰略價值。

深入分析揭示了產品設計、存取策略、作用機制、臨床適應症和最終用戶環境如何決定產品的採用管道和價值提案。

透過這種市場細分獲得的見解揭示了技術採納和臨床應用的重要細微差別，相關人員差別。根據產品類型，本研究對體外二氧化碳還原（ECCO2R）設備、膜式氧合器和滾壓泵的市場進行了分析，重點突出了優先考慮易用性的整合系統與可根據特定臨床通訊協定進行客製化的模組化組件之間的差異。 ECCO2R 設備在使用者介面、安全聯鎖和閉合迴路控制方面投入了工程研發，而膜式氧合器和滾壓泵則通常專注於改進材料科學和提高耐用性。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 採用新一代膜技​​術的低流量ECCO2R系統的引入降低了溶血和血栓症的風險。
  • 整合人工智慧驅動的監測平台，即時調整體外二氧化碳清除參數，以最佳化患者療效。
  • 開發攜帶式穿戴式二氧化碳清除裝置，用於門診和家庭治療慢性呼吸衰竭
  • ECCO2R 和連續性腎臟替代聯合治療在重症患者多重器官衰竭的臨床檢驗
  • 醫療器材製造商與製藥公司進行策略合作，共同開發輔助性治療以提高二氧化碳清除率
  • 在二氧化碳清除治療過程中，實施遠端監測和預測分析以提高安全性並縮短住院時間
  • 重點在於開發經濟高效的一次性組件和可擴展的生產流程，以提高ECCO2R系統的經濟性和市場可及性。
  • 監管政策的進步和報銷政策的更新推動了體外二氧化碳清除技術在加護病房的廣泛應用

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

第8章 體外二氧化碳清除裝置市場（依產品類型分類）

  • ECCO2R機器
  • 膜式氧合器
  • 滾筒幫浦

第9章 體外二氧化碳清除裝置市場（依接取方式分類）

  • 動脈和靜脈
  • 靜脈

第10章 體外二氧化碳清除裝置市場（依運作模式分類）

  • 自動化系統
  • 手動系統

第11章 體外二氧化碳清除裝置市場：依應用領域分類

  • 急性呼吸窘迫症候群
  • 肺移植橋樑
  • 慢性阻塞性肺病

第12章 體外二氧化碳清除裝置市場（依最終用戶分類）

  • 門診手術中心
  • 居家照護
  • 醫院
  • 專科診所

第13章 體外二氧化碳清除裝置市場：依地區分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 體外二氧化碳清除裝置市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國體外二氧化碳清除裝置市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Aferetica Srl
    • ALung Technologies, Inc. by LivaNova PLC
    • Baxter International Inc.
    • Dragerwerk AG & Co. KGaA
    • Edwards Lifesciences Corporation
    • Estor SpA
    • Fresenius Medical Care AG
    • Getinge AB
    • Inspira-Technologies OXY BHN LTD
    • Koninklijke Philips NV
    • LivaNova PLC
    • Medica SpA
    • MicroPort Scientific Corporation
    • Nikkiso Co., Ltd.
    • NovaLung GmbH
    • Terumo Corporation
    • X-COR Therapeutics
    • XENIOS AG by Fresenius Medical Care AG & Co. KGaA
Product Code: MRR-F927BA462E0F

The Extracorporeal CO2 Removal Devices Market is projected to grow by USD 287.05 million at a CAGR of 8.67% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 147.55 million
Estimated Year [2025] USD 159.68 million
Forecast Year [2032] USD 287.05 million
CAGR (%) 8.67%

A concise orientation to clinical need, device architectures, and stakeholder dynamics shaping the expanding role of extracorporeal CO2 removal in modern respiratory care

Extracorporeal CO2 removal has progressed from a specialized rescue technique to a versatile adjunctive therapy that intersects critical care, pulmonology, and surgical disciplines. Clinicians and hospital systems increasingly view extracorporeal CO2 removal as a targeted intervention for complex respiratory failure scenarios where conventional ventilation strategies are insufficient or carry unacceptable risks. As clinical pathways evolve and device engineering advances, a clearer picture is emerging of how extracorporeal CO2 removal can be integrated into broader respiratory care algorithms to reduce ventilator-induced lung injury, facilitate protective ventilation, and serve as a bridge for advanced therapies such as transplantation.

This introduction frames the clinical rationale, core device architectures, and the stakeholder landscape that together define current adoption dynamics. It highlights the interplay between device performance characteristics, procedural access strategies, and care settings that determine both clinical outcomes and operational feasibility. By establishing this foundation, readers can better appreciate subsequent discussions that focus on technological inflection points, policy disruptions, segmentation-specific opportunities, and regional considerations that will shape near-term decision-making for clinicians, hospital administrators, and device innovators.

How technological miniaturization, automation, and evolving clinical paradigms are jointly redefining device use cases, clinical pathways, and procurement priorities in extracorporeal CO2 removal

Several transformative shifts are reshaping how extracorporeal CO2 removal is conceived, designed, and deployed across clinical settings. Technological miniaturization and improvements in membrane performance are enabling less invasive circuits, lower blood flow requirements, and shorter set-up times, which in turn expand candidate populations beyond intensive care units. Concurrently, automation and embedded control algorithms are enhancing safety by stabilizing gas exchange parameters and reducing operator dependency, thereby lowering training burdens and broadening the pool of clinicians who can safely initiate therapy.

At the same time, clinical practice is shifting toward earlier intervention paradigms that prioritize lung protection and avoidance of high-intensity mechanical ventilation. This clinical emphasis is driving cross-functional collaboration between pulmonologists, intensivists, perfusionists, and surgical teams to develop integrated care pathways. Supply chain resilience and manufacturing agility have become strategic differentiators for device manufacturers, encouraging investment in modular designs and localized production lines. Finally, the maturation of evidence through registries and pragmatic trials is improving clarity on patient selection, timing, and comparative outcomes against conventional care, which collectively supports more standardized protocols and reimbursement conversations.

The cumulative consequences of new trade measures on manufacturing, procurement, and clinical continuity have prompted accelerated localization, supplier diversification, and risk mitigation strategies across the value chain

The imposition of tariffs and trade policy adjustments in 2025 has introduced a complex set of considerations for manufacturers, health systems, and procurement organizations that rely on global supply chains for extracorporeal CO2 removal technologies. Tariff-driven increases in component costs intensified scrutiny of supplier portfolios and incentivized a re-evaluation of sourcing strategies. Many device producers responded by optimizing bill-of-materials, accelerating supplier qualification for domestically sourced components, and reevaluating manufacturing footprints to reduce exposure to import-related cost volatility.

Hospitals and integrated health systems responded by enhancing procurement flexibility and renegotiating vendor contracts to incorporate clauses that address tariff fluctuations and lead time variability. Clinical teams faced indirect effects as some suppliers prioritized contractual partners for constrained production capacity, which necessitated closer collaboration between clinical engineering and supply chain groups to ensure continuity of care. In parallel, investment in local assembly and tooling increased, with an emphasis on quality control and regulatory alignment for domestically produced components. These shifts were accompanied by heightened regulatory scrutiny on device equivalence and traceability, leading to more robust documentation of component provenance and post-market surveillance practices. Collectively, the tariff-driven landscape accelerated localization trends, prioritized supplier diversification, and underscored the strategic value of vertical integration for companies looking to stabilize cost bases and deliver predictable supply to clinical customers.

Segmentation-driven insights reveal how product design, access strategy, operational mode, clinical indication, and end-user environment determine adoption pathways and value propositions

Insights derived from segmentation reveal important nuances in technology adoption and clinical application that stakeholders must consider when formulating strategy. Based on Product Types, market is studied across ECCO2R Machines, Membrane Oxygenators, and Roller pump, and this composition underscores a differentiation between integrated systems that prioritize ease of use and modular components that enable customization for specific clinical protocols. The ECCO2R machines concentrate engineering effort on user interfaces, safety interlocks, and closed-loop control, whereas membrane oxygenators and roller pumps are frequently the focus of incremental materials science and durability improvements.

Based on Access, market is studied across Arteriovenous and Venovenous, and this distinction materially affects procedural risk profiles, vascular access expertise requirements, and the types of clinical teams involved in device deployment. Arteriovenous approaches can offer simplified circuits in certain patient subsets but often require precise vascular assessment; venovenous access tends to be more familiar to critical care teams and integrates more readily with existing extracorporeal expertise. Based on Mode of Operation, market is studied across Automated Systems and Manual Systems, reflecting a bifurcation where automated solutions emphasize closed-loop regulation and reduced operator burden, while manual systems retain flexibility and lower capital intensity for settings with constrained resources. Based on Application, market is studied across Acute Respiratory Distress Syndrome, Bridge to Lung Transplant, and Chronic Obstructive Pulmonary Disease, which points to distinct clinical pathways: ARDS use tends to be acute and protocolized, bridge to transplant requires sustained and reliable support with rigorous infection controls, and COPD applications often emphasize outpatient stabilization and quality-of-life outcomes. Based on End User, market is studied across Ambulatory Surgical Centers, Home Care Settings, Hospitals, and Specialty Clinics, highlighting that deployment models vary from centralized tertiary care to decentralized ambulatory and home-based scenarios, each of which imposes different requirements for device portability, training programs, and post-market support.

Taken together, these segmentation lenses demonstrate that technical specifications, training models, and commercialization strategies cannot be one-size-fits-all. Successful product strategies will align device design with the procedural access profile, operational mode, clinical application, and end-user environment to create clear value propositions that address workflow realities and clinician preferences.

How geographic differences in clinical infrastructure, regulatory pathways, and supply chain resilience shape adoption dynamics and commercial entry strategies for extracorporeal CO2 removal

Regional dynamics create differentiated opportunities and constraints for extracorporeal CO2 removal development and deployment. In the Americas, strong hospital networks, active private equity interest in medical device scale-ups, and established centers of ECMO excellence create fertile ground for early clinical adoption, while reimbursement heterogeneity requires tailored evidence packages to support coverage decisions. Europe, Middle East & Africa presents a diverse regulatory and reimbursement environment where national health systems and regional centers of excellence can serve as strategic entry points, but market access strategies must account for country-level procurement practices and localized clinical guidelines. Asia-Pacific combines rapid hospital capacity expansion with growing domestic manufacturing capability, offering a dual pathway where multinational firms can partner with regional manufacturers to accelerate localization while addressing growing patient volumes in urban centers.

Across these regions, differences in clinician training models, standard-of-care respiratory management, and capital procurement cycles influence how quickly new extracorporeal CO2 removal technologies are adopted. Regional registries and investigator-led studies increasingly drive local guideline development, creating pathways for clinical evidence accumulation that are responsive to regional practice patterns. Furthermore, geographic variations in supply chain resilience and regulatory timelines affect lead times for device introduction and scaling, making region-specific commercial and clinical strategies essential for sustained adoption.

Competitive advantage is emerging for companies that pair engineering differentiation with clinical partnerships, resilient manufacturing, and evidence-driven commercialization strategies

Leading companies in the extracorporeal CO2 removal ecosystem are converging around several strategic imperatives that shape competition and collaboration. First, differentiated engineering investments-such as improved membrane materials, compact pump designs, and integrated monitoring platforms-are central to product roadmaps that aim to expand usability and reduce procedural complexity. Second, partnerships with clinical centers and integrated health systems are being used to generate real-world evidence, refine training protocols, and support early adopter programs that demonstrate clinical and operational value in representative care pathways.

Third, supply chain control and manufacturing agility are distinguishing capabilities; firms that secure multi-sourced critical components and invest in scalable assembly lines reduce exposure to disruptions and trade-policy impacts. Fourth, commercialization strategies increasingly blend direct sales to tertiary centers with distributor models for decentralized settings; this hybrid approach enables rapid penetration while preserving the ability to provide specialized training and service. Finally, companies are investing in post-market data capture and analytics to demonstrate long-term outcomes, inform iterative product improvements, and support reimbursement discussions. Collectively, these trends indicate that competitive advantage will accrue to organizations that combine robust engineering, pragmatic clinical collaboration, flexible commercial models, and resilient manufacturing practices.

Actionable guidance for device manufacturers and healthcare leaders to align product development, evidence generation, supply resilience, and training to accelerate safe adoption

Industry leaders should prioritize a set of actionable strategies to translate technical and clinical advances into durable adoption. First, align product development with clearly defined clinical use cases and procedural workflows, ensuring that device ergonomics, access requirements, and monitoring capabilities map directly to clinician needs and the realities of different care settings. Second, invest in scalable clinical evidence generation through pragmatic registries and multicenter observational studies that address outcomes important to payers, clinicians, and hospital administrators, thereby accelerating reimbursement dialogues and adoption.

Third, diversify sourcing and consider regional assembly hubs to reduce exposure to trade policy shifts and lead-time variability; balance this with robust supplier quality programs to maintain device performance and regulatory compliance. Fourth, build comprehensive training and credentialing programs that combine simulation-based modules with proctored initial procurements to shorten the learning curve and increase clinician confidence. Fifth, explore bundled service offerings that include remote monitoring, consumable management, and responsive field service to reduce total cost of ownership and simplify procurement decisions. Finally, pursue strategic partnerships with pulmonary and critical care opinion leaders to co-develop best-practice protocols that harmonize device use across institutions and support standardized reimbursement claims.

A methodical synthesis of clinical literature, regulatory mapping, expert interviews, and supply chain analysis that triangulates evidence to inform practical decision-making for stakeholders

The research approach combined a structured review of clinical literature, regulatory filings, and publicly available device specifications with targeted expert consultations and supply chain analysis to build a comprehensive understanding of extracorporeal CO2 removal technologies. Clinical evidence was synthesized from peer-reviewed studies, registry reports, and procedural guidelines to delineate use-case definitions, safety profiles, and outcome metrics that clinicians and payers find persuasive. Regulatory pathways were mapped using device approval summaries and guidance documents to identify critical compliance considerations for deployment in different jurisdictions.

Complementing these sources, interviews were conducted with practicing intensivists, perfusionists, hospital procurement leaders, and device engineers to surface operational realities, training challenges, and technology preferences. Supply chain mapping examined component criticality, geographic concentration of suppliers, and manufacturing constraints to assess vulnerability to trade disruptions. Findings were validated through triangulation across independent information streams and by cross-referencing clinical insights with operational data. Limitations include potential lag between newly published clinical results and their incorporation into this analysis and variability in local practice that may influence adoption nuances; where appropriate, assumptions and source timing were documented to support transparent interpretation of the findings.

A concise synthesis of technological progress, clinical adoption drivers, and strategic priorities that frames the practical pathways for durable integration of extracorporeal CO2 removal

In summary, extracorporeal CO2 removal stands at an inflection point where technological progress, evolving clinical approaches, and supply chain dynamics collectively create new opportunities and responsibilities for device makers and healthcare providers. Advances in membrane technology and automation are lowering barriers to use, while diversified access strategies and growing outpatient considerations are expanding the therapy's potential applications. Trade-policy shifts and tariff-related pressures have underscored the importance of supply chain resilience and manufacturing flexibility, prompting a strategic reorientation toward localized sourcing and robust supplier networks.

The path forward requires coordinated action: developers must align engineering priorities with real-world workflows; clinical leaders should collaborate to generate pragmatic evidence that addresses patient-centered outcomes and payer priorities; and procurement teams must incorporate supply continuity and total cost of ownership into purchase decisions. When these elements coalesce, extracorporeal CO2 removal can move from a specialized rescue therapy toward a reliable component of respiratory care strategy that improves patient outcomes while fitting within institutional operational constraints.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of low-flow ECCO2R systems leveraging next-generation membrane technology to reduce hemolysis and thrombosis risk
  • 5.2. Integration of AI-driven monitoring platforms for real-time adjustment of extracorporeal CO2 removal parameters to optimize patient outcomes
  • 5.3. Development of portable and wearable CO2 removal devices for ambulatory care and home-based chronic respiratory failure management
  • 5.4. Clinical validation of combined ECCO2R and continuous renal replacement therapies for multiorgan support in critically ill patients
  • 5.5. Strategic partnerships between device manufacturers and pharmaceutical companies to co-develop adjunctive therapies improving carbon dioxide clearance efficacy
  • 5.6. Implementation of remote telemonitoring and predictive analytics to enhance safety and reduce hospital stay durations in CO2 removal therapy
  • 5.7. Focus on cost-effective disposable components and scalable manufacturing processes to improve affordability and market accessibility of ECCO2R systems
  • 5.8. Regulatory advancements and reimbursement policy updates driving broader adoption of extracorporeal CO2 removal technologies in intensive care units

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Extracorporeal CO2 Removal Devices Market, by Product Types

  • 8.1. ECCO2R Machines
  • 8.2. Membrane Oxygenators
  • 8.3. Roller pump

9. Extracorporeal CO2 Removal Devices Market, by Access

  • 9.1. Arteriovenous
  • 9.2. Venovenous

10. Extracorporeal CO2 Removal Devices Market, by Mode of Operation

  • 10.1. Automated Systems
  • 10.2. Manual Systems

11. Extracorporeal CO2 Removal Devices Market, by Application

  • 11.1. Acute Respiratory Distress Syndrome
  • 11.2. Bridge to Lung Transplant
  • 11.3. Chronic Obstructive Pulmonary Disease

12. Extracorporeal CO2 Removal Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Home Care Settings
  • 12.3. Hospitals
  • 12.4. Specialty Clinics

13. Extracorporeal CO2 Removal Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Extracorporeal CO2 Removal Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Extracorporeal CO2 Removal Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Aferetica Srl
    • 16.3.2. ALung Technologies, Inc. by LivaNova PLC
    • 16.3.3. Baxter International Inc.
    • 16.3.4. Dragerwerk AG & Co. KGaA
    • 16.3.5. Edwards Lifesciences Corporation
    • 16.3.6. Estor S.p.A
    • 16.3.7. Fresenius Medical Care AG
    • 16.3.8. Getinge AB
    • 16.3.9. Inspira-Technologies OXY B.H.N. LTD
    • 16.3.10. Koninklijke Philips N.V.
    • 16.3.11. LivaNova PLC
    • 16.3.12. Medica S.p.A
    • 16.3.13. MicroPort Scientific Corporation
    • 16.3.14. Nikkiso Co., Ltd.
    • 16.3.15. NovaLung GmbH
    • 16.3.16. Terumo Corporation
    • 16.3.17. X-COR Therapeutics
    • 16.3.18. XENIOS AG by Fresenius Medical Care AG & Co. KGaA

LIST OF FIGURES

  • FIGURE 1. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ECCO2R MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ECCO2R MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ECCO2R MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ECCO2R MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ECCO2R MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ECCO2R MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE OXYGENATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE OXYGENATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE OXYGENATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE OXYGENATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE OXYGENATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE OXYGENATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ROLLER PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ROLLER PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ROLLER PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ROLLER PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ROLLER PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ROLLER PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ARTERIOVENOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ARTERIOVENOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ARTERIOVENOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ARTERIOVENOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ARTERIOVENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ARTERIOVENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY VENOVENOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY VENOVENOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY VENOVENOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY VENOVENOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY VENOVENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY VENOVENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MANUAL SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MANUAL SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MANUAL SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MANUAL SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY BRIDGE TO LUNG TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY BRIDGE TO LUNG TRANSPLANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY BRIDGE TO LUNG TRANSPLANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY BRIDGE TO LUNG TRANSPLANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY BRIDGE TO LUNG TRANSPLANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY BRIDGE TO LUNG TRANSPLANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 103. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 105. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 111. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 116. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 118. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 120. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 128. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 130. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 164. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 166. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 168. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 176. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 177. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 178. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 179. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 180. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 181. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 202. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 203. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 204. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 205. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 206. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 207. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 214. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 215. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 216. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 217. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 218. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 219. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 235. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 238. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 239. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 240. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 241. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 242. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 243. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 250. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 251. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 252. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 253. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 254. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 255. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 262. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 263. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 264. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 265. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 266. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 267. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 274. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 275. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 276. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 277. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 278. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 279. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 282. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 283. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2024 (USD MILLION)
  • TABLE 284. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT TYPES, 2025-2032 (USD MILLION)
  • TABLE 285. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2018-2024 (USD MILLION)
  • TABLE 286. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY ACCESS, 2025-2032 (USD MILLION)
  • TABLE 287. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 288. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 289. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. CANADA EXTRACORPOREAL CO2 R